Form 4 · Filed Jun 5, 2026, 08:19 PM UTC
ALDX/Aldeyra Therapeutics, Inc.
Brady Todd C — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | P | buy | 250,000 | $2 | $418,450 | 1,721,298 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-259637